Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Enzyme Inhibition

Enzyme Inhibition

Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.

Inhibitors of Bacterial Protein Synthesis

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...

Inhibitors of Gram-positive Cell Wall Synthesis

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...

Ribozymes

Ribozymes

The term ribozyme is used for RNA that can act as an enzyme. Ribozymes are mainly found in selected viruses, bacteria, plant organelles, and lower eukaryotes. Ribozymes were first discovered in 1982 when Tom Cech’s laboratory observed Group I introns acting as enzymes. This was shortly followed by the discovery of another ribozyme, Ribonulcease P, by Sid Altman’s laboratory. Both Cech and Altman received the Nobel Prize in chemistry in 1989 for their work on ribozymes.
Ribozymes can be...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A novel Kazal-type protease inhibitor from Aedes aegypti effective for NS2B-NS3 protease from the Zika virus and subtilases.

Archives of biochemistry and biophysics·2026

Same author

The gut microbiota composition of Trichoplusia ni is altered by diet and may influence its polyphagous behavior.

Scientific reports·2021

Same author

Soybean leghemoglobin targeted to potato chloroplasts influences growth and development of transgenic plants.

Plant cell reports·2019

Same author

Novel pseudo-aspartic peptidase from the midgut of the tick Rhipicephalus microplus.

Scientific reports·2019

Same author

Selection and validation of reference house-keeping genes in the J774A1 macrophage cell line for quantitative real-time PCR.

Genetics and molecular research : GMR·2016

Same author

EPI-peptide designer: a tool for designing peptide ligand libraries based on epitope-paratope interactions.

Bioinformatics (Oxford, England)·2016

Search research articles

Related Experiment Video

Updated: Jul 9, 2026

The Determination of Protease Specificity in Mouse Tissue Extracts by MALDI-TOF Mass Spectrometry: Manipulating PH to Cause Specificity Changes

The Determination of Protease Specificity in Mouse Tissue Extracts by MALDI-TOF Mass Spectrometry: Manipulating PH to Cause Specificity Changes

Published on: May 25, 2018

Proteinase inhibition using small Bowman-Birk-type structures.

J H Fernandez¹, M O Mello, L Galgaro

¹LabInfo, LNCC, Petrópolis, RJ, Brasil.

Genetics and Molecular Research : GMR

|December 7, 2007

Summary

This summary is machine-generated.

Bowman-Birk inhibitors (BBIs) are small proteins that inhibit digestive enzymes. Computational studies revealed a mutant BBI (ChyTB2) effectively inhibits both trypsin and chymotrypsin through distinct binding interactions.

More Related Videos

The Importance of Correct Protein Concentration for Kinetics and Affinity Determination in Structure-function Analysis

The Importance of Correct Protein Concentration for Kinetics and Affinity Determination in Structure-function Analysis

Published on: March 17, 2010

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

Related Experiment Videos

Last Updated: Jul 9, 2026

The Determination of Protease Specificity in Mouse Tissue Extracts by MALDI-TOF Mass Spectrometry: Manipulating PH to Cause Specificity Changes

The Determination of Protease Specificity in Mouse Tissue Extracts by MALDI-TOF Mass Spectrometry: Manipulating PH to Cause Specificity Changes

Published on: May 25, 2018

The Importance of Correct Protein Concentration for Kinetics and Affinity Determination in Structure-function Analysis

The Importance of Correct Protein Concentration for Kinetics and Affinity Determination in Structure-function Analysis

Published on: March 17, 2010

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

Area of Science:

Biochemistry
Structural Biology
Computational Biology

Background:

Bowman-Birk inhibitors (BBIs) are small, cysteine-rich proteins that inhibit digestive proteinases.
BBIs possess a double-headed structure with independent loops for binding trypsin, chymotrypsin, and elastase.

Purpose of the Study:

To investigate the structural characteristics and inhibition dynamics of a modified BBI loop (ChyTB2 inhibitor).
To analyze the binding interactions of ChyTB2 with trypsin and chymotrypsin using computational methods.

Main Methods:

Computational biology techniques, including molecular modeling and dynamics simulations.
Enzyme-linked immunosorbent assay (ELISA) to validate computational findings.

Main Results:

BBI-trypsin inhibition involves salt bridges and hydrogen bonds.
BBI-chymotrypsin inhibition is primarily driven by hydrophobic interactions.
The ChyTB2 mutant maintained its structure and effectively inhibited both trypsin and chymotrypsin.

Conclusions:

Computational modeling and molecular dynamics are effective for predicting and designing novel proteinase inhibitors.
Designing small BBI-type inhibitors requires understanding the specific binding interactions of mutants with target proteinases.